FDA Harmonizes Worldwide Dewormer Standards for Dogs
Published Date: 6/24/2026
Notice
Summary
The FDA just released new guidance to help companies test worm-killing medicines for dogs. This makes it easier for drug makers worldwide to prove their products work, speeding up approvals and keeping pups healthier. If you’re in the veterinary medicine business, this update could save time and money starting now!
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Harmonized testing rules for dog dewormers
If you make worm‑killing medicines for dogs, FDA released final guidance GFI #111 on June 24, 2026 that gives study design recommendations for canines. The guidance is intended to help regulators in the European Union, Japan, and the United States universally accept the effectiveness data and to reduce differences in technical requirements for drug development; it was endorsed by VICH regulatory agencies in October 2024.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12622 — Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Revised Draft Guidance for Industry; Availability
The FDA just released a new draft guide to help drug makers prove their medicines really work, using smarter and faster science. This update affects companies developing human drugs and biological products, aiming to save time and money by allowing strong evidence from just one good clinical study plus extra proof. Comments on this draft are open until September 22, 2026, so industry folks have a chance to weigh in before it becomes final.
2026-12620 — Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability
The FDA just dropped a fresh draft guidance to help drug and biological product makers run smarter, faster clinical trials using master protocols. This update affects companies developing new medicines by clarifying how to design and submit these trials for approval. If you’re in the game, get your comments in by August 24, 2026, or risk missing out on shaping the final rules—and maybe saving time and money down the road!
2026-12681 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Caprines; Guidance for Industry; Availability
The FDA just released new guidance to help drug makers prove their worm-killing medicines work well in goats. This makes it easier for companies worldwide to get their products approved by following the same rules. Goat farmers, vets, and drug companies should watch for these updates starting June 24, 2026, which could speed up getting effective treatments to animals without extra costs.
2026-12621 — Expedited Investigational New Drug Pilot Program; Request for Information
The FDA wants to speed up how fast new drugs get tested on people by creating a special pilot program. This program will team up trusted research groups with drug makers to review early study plans faster, while keeping safety top priority. If you’re involved in drug research or healthcare, now’s your chance to share ideas before July 22, 2026!
2026-12679 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Bovines; Guidance for Industry; Availability
The FDA just released new guidance to help companies test worm-killing medicines for cows. This makes it easier for drug makers worldwide to prove their products work, speeding up approvals and keeping cattle healthy. Farmers, vets, and drug companies should watch for these changes starting now—no extra costs, just clearer rules!
2026-12685 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Felines; Guidance for Industry; Availability
The FDA just released new guidance to help vets and drug makers prove how well deworming medicines work for cats. This makes it easier to get these medicines approved worldwide by using the same testing rules. If you’re in the pet medicine business, this update helps speed up approvals and keeps our feline friends healthier—starting now!
Previous / Next Documents
Previous: 2026-12683 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Porcines; Guidance for Industry; Availability
The FDA just released new guidance to help vets and drug makers test worm-killing medicines for pigs. This makes it easier to get these medicines approved worldwide by using the same testing rules. If you work with pig medicines, start following these recommendations now to save time and money on approvals.
Next: 2026-12685 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Felines; Guidance for Industry; Availability
The FDA just released new guidance to help vets and drug makers prove how well deworming medicines work for cats. This makes it easier to get these medicines approved worldwide by using the same testing rules. If you’re in the pet medicine business, this update helps speed up approvals and keeps our feline friends healthier—starting now!